Zabicipril

This classification denotes an ace inhibitor with the molecular formula C23H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 475035SS4C, chemically known as (3s)-2-((2s)-n-((1s)-1-carboxy-3-phenylpropyl)alanyl)-2-azabicyclo(2.2.2)octane-3-carboxylic acid, 1-ethyl ester but generally known as zabicipril, which bears US NIH Compound Identifier 71262. European Medicines Agency schedules Zabicipril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00125MIG. The term ZABICIPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). ZABICIPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zabicipril under HS 29333999 and SITC 51574. As of Q4 2014, ZABICIPRIL remains the US FDA Preferred Term for this commodity. Zabicipril bears US NLM identifiers UMLS ID C0085048 and NCI Concept Code C82218. SMILES: OC(=O)C1N(C2CCC1CC2)C(=O)C(NC(CCc1ccccc1)C(=O)OCC)C.